(May 20, 2022)-The team at Clearview Cancer Institute has been involved in cancer research for more than three decades. We have a department dedicated to research and clinical trials. Our commitment remains with new targeted therapies, better detection methods, genomic testing and personalized medicine.
Pictured: Lisa Chapuran, Mary Hughes, Mariam Parizad, Leslie Smoot
Did you know:
- The CCI research team has participated in the FDA approval of the following medications: Herceptin, Avastin, Rituxan and more.
- The CCI research team has a combined 30 years experience in research including 4 RNs that serve as study coordinators, a regulatory/investigational product coordinator, and a lab and registry coordinator.
- Clinical trials have improved childhood cancer survival from less than 10% to 80% survival.
- Clinical trials can allow access to therapies that are up and coming and not available otherwise.
- Developing new medicine takes at least 10 years on average to receive FDA approval.
- Clinical trials look at new ways to prevent, detect, or treat disease.
- Groundbreaking scientific advances in the present and the past were possible only because of participation of volunteers, both healthy and those diagnosed with an illness, in clinical research.
A special thanks to these physicians who serve as primary investigators:
Dr. Paul Dang
Dr. Jorge Diaz
Dr. Kanth Katragadda
Dr. Brian Mathews
Dr. Daniel Schreeder
Dr. Marshall Schreeder